<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03704935</url>
  </required_header>
  <id_info>
    <org_study_id>RECHMPL18_0317</org_study_id>
    <nct_id>NCT03704935</nct_id>
  </id_info>
  <brief_title>Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program</brief_title>
  <acronym>LTAir+R</acronym>
  <official_title>Long Term Effects and of a Pulmonary Rehabilitation Maintenance Program in Patients With a Chronic Respiratory Disease: Time Course and Determinants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Montpellier</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Montpellier</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Chronic respiratory diseases are characterized by a progressive and long term deline.
      Pulmonary rehabilitation (exercise training and therapeutic education) can improve several
      disease outcomes like dyspnea, exercise tolerance and health-related quality of life. After
      an inpatient PR program, maintenance program can stabilize the disease outcomes. However,
      maintenance program are heterogeneous and long term benefits (&gt;36 month) have been observed
      in only one study, which is not feasible in France. A realistic maintenance program as
      proposed by the French Air+R network (http://airplusr.com/wordpress/) has only demonstrated
      benefits after 12 month. In addition, the time course of patients may be heterogeneous, with
      differens clusters that could be influenced by the clinical, functional and systemic
      determinants. In particular, the cellular muscle microenvironment could be deleterious for
      the muscle function in patients, caused by a &quot;spill-over&quot; of inflammatory pulmonary molecules
      in the systemic milieu.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 10, 2018</start_date>
  <completion_date type="Actual">December 30, 2019</completion_date>
  <primary_completion_date type="Actual">April 30, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>6 minutes walking distance</measure>
    <time_frame>10 years</time_frame>
    <description>6 minutes walking distance</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>health-related quality of life</measure>
    <time_frame>10 years</time_frame>
    <description>health-related quality of life : VQ-11 questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Forced expiratory volume in 1 seconde</measure>
    <time_frame>10 years</time_frame>
    <description>Forced expiratory volume in 1 seconde : FEV1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>BODE index</measure>
    <time_frame>10 years</time_frame>
    <description>BODE index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death</measure>
    <time_frame>10 years</time_frame>
    <description>death</description>
  </secondary_outcome>
  <enrollment type="Actual">1000</enrollment>
  <condition>Chronic Respiratory Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with a chronic respiratory disease (COPD, Asthma, bronchiectasis , Fibrosis, Sleep
        Apnea, …) undergoing pulmonary rehabilitation (maintenance or inpatient)
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

        Patients with a chronic respiratory disease (COPD, Asthma, bronchiectasis , Fibrosis, Sleep
        Apnea, …) undergoing pulmonary rehabilitation (maintenance or inpatient)

        Exclusion criteria:

        Contraindication to exercise training
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Farés Gouzi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Montpellier</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of clinical Physiology - University Hospital</name>
      <address>
        <city>Montpellier</city>
        <zip>34295</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>October 10, 2018</study_first_submitted>
  <study_first_submitted_qc>October 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 15, 2018</study_first_posted>
  <last_update_submitted>March 9, 2020</last_update_submitted>
  <last_update_submitted_qc>March 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Pulmonary rehabilitation</keyword>
  <keyword>Maintenance program</keyword>
  <keyword>Cohort</keyword>
  <keyword>Microenvironment</keyword>
  <keyword>Long-term benefits</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiration Disorders</mesh_term>
    <mesh_term>Respiratory Tract Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

